Drug
Antiarrhythmic drugs
Antiarrhythmic drugs is a pharmaceutical drug with 6 clinical trials. Historical success rate of 50.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 2 completed trials
Completion Rate
50%(2/4)
Active Trials
0(0%)
Results Posted
100%(2 trials)
Terminated
2(33%)
Phase Distribution
Ph phase_3
2
33%
Ph phase_4
3
50%
Phase Distribution
0
Early Stage
0
Mid Stage
5
Late Stage
Phase Distribution5 total trials
Phase 3Large-scale testing
2(40.0%)
Phase 4Post-market surveillance
3(60.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
50.0%
2 of 4 finished
Non-Completion Rate
50.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Active(1)
Completed(2)
Terminated(2)
Other(1)
Detailed Status
Terminated2
Completed2
unknown1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
50.0%
Most Advanced
Phase 4
Trials by Phase
Phase 32 (40.0%)
Phase 43 (60.0%)
Trials by Status
unknown117%
not_yet_recruiting117%
terminated233%
completed233%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_4
Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial Fibrillation
NCT01803438
terminatedphase_4
CACAF2 Study: Catheter Ablation for Cure of Atrial Fibrillation
NCT00227344
not_yet_recruiting
The Use of Antiarrhythmic Drugs in Pediatrics
NCT06272357
unknownphase_4
PROSPECTIVE ANALYSIS BETWEEN AMIODARONE Versus LIDOCAINE IN SVT
NCT03299517
completedphase_3
Antiarrhythmic Therapy Versus Catheter Ablation for Atrial Fibrillation in Hypertrophic Cardiomyopathy
NCT00821353
Clinical Trials (6)
Showing 6 of 6 trials
NCT01803438Phase 4
Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial Fibrillation
NCT00227344Phase 4
CACAF2 Study: Catheter Ablation for Cure of Atrial Fibrillation
NCT06272357
The Use of Antiarrhythmic Drugs in Pediatrics
NCT03299517Phase 4
PROSPECTIVE ANALYSIS BETWEEN AMIODARONE Versus LIDOCAINE IN SVT
NCT00821353Phase 3
Antiarrhythmic Therapy Versus Catheter Ablation for Atrial Fibrillation in Hypertrophic Cardiomyopathy
NCT00741611Phase 3
Study of HD Mesh Ablation System for Treatment of Paroxysmal Atrial Fibrillation
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6